Early Access — free while we kick the tires
EdgarHawk

Somaiya Mayur Ian

Chief Financial Officer

Officer
1 filing analyzed · 1 company · Latest 2026-01-22

Companies

Company Buys Sells Direction
NewAmsterdam Pharma Co N.V. NAMS 0 7 Net selling

Activity

January 2026
high
Sell
100,000 shares
$3,260,618
Significance 7/10

CFO Somaiya Mayur Ian sold 100,000 shares (63.1% of holdings) for $3.3M at NAMS on Jan 20-21.

Somaiya Mayur Ian, Chief Financial Officer, executed 5 separate sales totaling 100,000 shares (100.0K shares) for $3,260,617.98 ($3.3M) over January 20-21, reducing his holdings from 158,382 shares to 58,382 shares—a 63.1% reduction in stake. The company is deeply unprofitable with a net income of $-72,005,000.00 ($-72.0M) in its most recent full fiscal year, while the CFO divested at prices ranging from $30.64 to $33.80 against a current price of $34.81. This large proportional reduction in the CFO's holdings at a company operating at significant losses merits close examination of the insider's confidence posture and any contemporaneous business developments or financing needs that may have prompted the liquidation.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access